Fundraising Fox
George Medicines
2 known investors
Find your way into George Medicines
Each arrow is one introduction. Sign up to fill in the first one.
Ask Steven C. Jones to introduce you to Mark Mallon
You →Steven · together at NeoGenomics →Mark
Ask Jamie Chen to introduce you to Dr Karl Roberts
You →Jamie · together at Cipla →Dr
Sign up to find every way you can get introduced to George Medicines
- Your email: who you already know at George Medicines, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the George Medicines team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
George Medicines develops single-pill combination therapies for cardiometabolic diseases such as hypertension and diabetes, leveraging research from The George Institute for Global Health. The company targets patients with low medication adherence and aims to reduce the burden of non-communicable diseases on patients, families, and health systems.
Founders & leadership
Investors · 2
In the news
Frequently asked questions
- What does George Medicines do?
- George Medicines develops single-pill combination therapies for cardiometabolic diseases such as hypertension and diabetes, leveraging research from The George Institute for Global Health. The company targets patients with low medication adherence and aims to reduce the burden of non-communicable diseases on patients, families, and health systems.
- Who are George Medicines's investors?
- George Medicines's investors include Brandon BioCatalyst, Brandon Capital Partners.